Article Text

Download PDFPDF
Hepatitis B vaccination in a high risk MSM population: the need for vaccine education
  1. Scott D Rhodes,
  2. Ralph J Diclemente,
  3. Leland J Yee,
  4. Kenneth C Hergenrather
  1. Department of Health Behavior, School of Public Health, University of Alabama, Birmingham, Alabama, USA
  2. Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
  3. Department of Epidemiology and International Health, School of Public Health, University of Alabama, Birmingham, Alabama, USA
  4. Department of Rehabilitation, Auburn University, Auburn, Alabama, USA
  1. Ralph J DiClemente, PhD, Rollins School of Public Health, Emory University, 1518 Clifton Road, NE; BSHE/5th Floor, Atlanta, GA 30322, USArdiclem{at}sph.emory.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Editor,—Estimates of the prevalence of hepatitis B virus (HBV) markers among men who have sex with men (MSM) range from 5% to 81%, and the prevalence of HBV surface antigen varies from 1% to 11%.1,2 Despite a safe and effective vaccine against HBV, sexually active MSM are not vaccinated adequately.2–5 Few empirical data describe the factors associated with HBV vaccination among MSM. We conducted a study to identify correlates of HBV vaccination among MSM that could inform future interventions designed to enhance HBV …

View Full Text